Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects von Indrová, M, Reinis, M, Bubeník, J, Jandlová, T, Bieblová, J, Vonka, V, Velek, J

Volltext

Immunotherapeutic efficacy of vaccines generated by fusion of dendritic cells and HPV16-associated tumour cells von Simova, J, Bubenik, J, Bieblova, J, Indrova, M, Jandlova, T

Volltext

The role of NK1.1+ cells in the protection against MHC class I+ HPV16-associated tumours von Símová, J, Bubeník, J, Bieblová, J, Jandlová, T

Volltext

Immunotherapy of HPV 16-associated tumours with tumour cell line/dendritic cell line (TC-1/DC2.4) hybrid vaccines von Simova, J, Bieblova, J, Jandlova, T, Bubenik, J

Volltext

MHC class I+ and class I- HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments von Símová, J, Mikysková, R, Vonka, V, Bieblová, J, Bubeník, J, Jandlová, T

Volltext

Local IFN-gamma therapy of HPV16-associated tumours von Mikysková, R, Bieblová, J, Símová, J, Indrová, M, Jandlová, T, Vonka, V, Smahel, M, Bubeník, J, Mendoza, L

Volltext

Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: cytolytic activity of spleen cells from tumour regressors von Indrová, M, Mikysková, R, Jandlová, T, Vonka, V, Bubeník, J, Bieblová, J

Volltext

Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2 von BUBENIK, J, SIMOVA, J, JANDLOVA, T

Volltext

Immunotheraphy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2 von Bubeník, J., Šimová, J., Jandlová, T.

Volltext

Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth von Mendoza, L, Indrová, M, Hájková, R, Reinis, M, Smahel, M, Vonka, V, Bubeník, J, Jandlová, T

Volltext

Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines von Símová, J, Reinis, M, Sobota, V, Capková, J, Bubeník, J, Jandlová, T

Volltext

Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms von Mendoza, L, Bubeník, J, Símová, J, Korb, J, Bieblová, J, Vonka, V, Indrová, M, Mikysková, R, Jandlová, T

Volltext

Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases von Mikysková, R, Bubenik, J, Mendoza, L, Vonka, V, Smahel, M, Símová, J, Jandlová, T

Volltext

Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours von INDROVA, Marie, BIEBLOVA, Jana, JANDLOVA, Tana, VONKA, Vladimir, PAJTASZ-PIASECKA, Elzbieta, REINIS, Milan

Volltext

Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma von Bubeník, J., Kieler, J., Tromholt, V., Hermann, G., Jandlová, T.

Volltext

Use of IL-2 gene transfer in local immunotherapy of cancer von BUBENIK, J, LOTZOVA, E, INDROVA, M, SIMOVA, J, JANDLOVA, T, BUBENIKOVA, D

Volltext

Intratumoral IL-12 gene transfer improves the therapeutic efficacy of IL-12 but not IL-19 von Sobota, V, Bubeník, J, Símová, J, Jandlová, T

Volltext

Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours von REINIS, Milan, SIMOVA, Jana, INDROVA, Marie, BIEBLOVA, Jana, PRIBYLOVA, Hana, MORAVCOVA, Simona, JANDLOVA, Tana, BUBENFK, Jan

Volltext

Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report von Bubeník, J, Perlmann, P, Indrová, M, Símová, J, Jandlová, T, Neuwirt, J

Volltext

Intratumoral IL-2 Gene Transfer Improves the Therapeutic Efficacy of IL-12 but Not IL-18 von Sobota, V, Bubenik, J, Simova, J, Jandlova, T

Volltext